Dermatomyositis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
Conditions:   Dermatomyositis;   Abatacept Intervention:   Drug: Abatacept Sponsors:   The First Affiliated Hospital with Nanjing Medical University;   National Natural Science Foundation of China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials